Hartford Investment Management Co (HIMCO)’s Nektar Therapeutics NKTR Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,213	Closed	-$332K	–	556
2019 Q3	$332K	Sell	1,213 -25	-2%	-$9.17K	0.01%	539
2019 Q2	$661K	Buy	1,238 +3	+0.2%	+$1.5K	0.02%	490
2019 Q1	$623K	Sell	1,235 -505	-29%	-$299K	0.02%	495
2018 Q4	$858K	Buy	1,740 +41	+2%	+$24.7K	0.03%	467
2018 Q3	$1.55M	Buy	1,699 +338	+25%	+$288K	0.05%	387
2018 Q2	$997K	Sell	1,361 -645	-32%	-$744K	0.03%	480
2018 Q1	$3.2M	Buy	+2,006	New	+$2.58M	0.06%	353

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s NKTR Position: Q4 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 1,213 shares — an estimated $332K sold.

Hartford Investment Management Co (HIMCO) first reported a position in NKTR in Q1 2018 and held it in 7 quarters. The position peaked at $3.2M in Q1 2018. 281 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

Hartford Investment Management Co (HIMCO) reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
Hartford Investment Management Co (HIMCO) sold 1,213 Nektar Therapeutics shares in Q4 2019, an estimated $332K.
Hartford Investment Management Co (HIMCO) first reported a position in Nektar Therapeutics in Q1 2018 and held it in 7 quarters.
Hartford Investment Management Co (HIMCO)'s Nektar Therapeutics position peaked at $3.2M in Q1 2018.
281 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2019, filed 29 Jan 2020.